1. EU, Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 Concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC, OJ. L 396 (2006) 1–849. http://data.europa.eu/eli/reg/2006/1907/oj.
2. ICH, ICH guideline M7 (R1) on assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk, European Medicines Agency, 2017. https://database.ich.org/sites/default/files/M7_R1_Guideline.pdf.
3. Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses;Amberg;Regul. Toxicol. Pharmacol.,2016
4. Computational toxicology and drug discovery;Hasselgren;Methods Mol. Biol.,2018
5. Adverse Outcome Pathway (AOP) informed modeling of aquatic toxicology: QSARs, read-across, and interspecies verification of modes of action;Ellison;Environ. Sci. Technol.,2016